TY  - GEN
AU  - Reardon,David A
AU  - Wen,Patrick Y
AU  - Alfred Yung,W K
AU  - Berk,Lori
AU  - Narasimhan,Narayana
AU  - Turner,Christopher D
AU  - Clackson,Timothy
AU  - Rivera,Victor M
AU  - Vogelbaum,Michael A
TI  - Ridaforolimus for patients with progressive or recurrent malignant glioma: a perisurgical, sequential, ascending-dose trial
SN  - 1432-0843
PY  - 2012///0727
KW  - Adult
KW  - Aged
KW  - Antibiotics, Antineoplastic
KW  - adverse effects
KW  - Cohort Studies
KW  - Combined Modality Therapy
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Female
KW  - Glioma
KW  - drug therapy
KW  - Humans
KW  - Immunohistochemistry
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Sirolimus
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s00280-011-1773-y
ER  -